Bayer sells $3.4B stake in contraceptives business to Apollo
Seeking Alpha ·
Bayer ( BAYRY ) has secured €3B ($3.4B) in equity capital through an agreement with global asset manager Apollo ( APO ) to strengthen its capital structure. Under the deal, Apollo-managed funds and affiliates will acquire a minority, non-controlling stake in a newly created entity holding
DYAX Investor Sentiment
Bullish (Long) 39% · Bearish (Short) 61%
363 participants
Related News
- Medaro Mining names new CEO
- Delta Air Lines Non-GAAP EPS of $1.56 beats by $0.06, revenue of $19.8B beats by $950M
- ChipMOS posts record monthly, quarterly revenue since 2014
- Ionis Pharmaceuticals reiterates FY26 outlook, unchanged from April projections
- Palantir Stock Is Down 36% From Its All-Time High. Time to Buy?
- AM Markets Need to Know: SK Hynix raises record $26.5B, IEA sees oil demand falling